Search

Fiona Mcphee

from Watertown, MA
Age ~60
Get Report
Also known as:
Fiona Mcphere, Fiona Good
Phone and address:
34 Dexter Ave, Watertown, MA 02472
(203) 715-0148
Related to:
Michelle Berrones, 55Chad G Wagner, 51Debra Lanier, 49Joan Sweigart, 73Alicia M Berrones, 56
Connected to:
Ainsley P Mcphee, 85Bonita H Mcphee, 60Bryan K Mcphee, 63Caroline G Mcphee, 48Casey W Mcphee, 35Danielle L Mcphee, 47Dari L Mcphee, 55Diana Mcphee, 55Douglas Mcphee, 48Dwan Mcphee, 54

Fiona Mcphee Phones & Addresses

  • 34 Dexter Ave, Watertown, MA 02472 (203) 715-0148
  • Wallingford, CT
  • Rocky Hill, CT
  • San Francisco, CA
  • 52 High Hill Rd, Wallingford, CT 06492

Publications

Us Patents

Hepatitis C Virus Inhibitors

View page
US Patent:
7132504, Nov 7, 2006
Filed:
Nov 10, 2004
Appl. No.:
10/985106
Inventors:
Paul Michael Scola - Glastonbury CT, US
Fiona McPhee - Wallingford CT, US
Nicholas A Meanwell - East Hampton CT, US
Piyasena Hewawasam - Middletown CT, US
Jeffrey Allen Campbell - Glen Gardner NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/00
US Classification:
530 18
Abstract:
Compounds are disclosed having the general formula:.

Macrocyclic Isoquinoline Peptide Inhibitors Of Hepatitis C Virus

View page
US Patent:
7173004, Feb 6, 2007
Filed:
Apr 16, 2004
Appl. No.:
10/825693
Inventors:
Fiona McPhee - Wallingford CT, US
Jeffrey Allen Campbell - Glen Gardner NJ, US
Stanley D'Andrea - Meriden CT, US
Zhizhen Barbara Zheng - Cheshire CT, US
Andrew Charles Good - Wallingford CT, US
David J. Carini - Wallingford CT, US
Barry L. Johnson - Wallingford CT, US
Paul Michael Scola - Glastonbury CT, US
Kenneth M. Boy - Durham CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/00
US Classification:
514 10
Abstract:
Macrocyclic isoquinoline peptides are disclosed having the general formula:A compound of formula I:wherein Rto R, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

View page
US Patent:
7741281, Jun 22, 2010
Filed:
Nov 1, 2006
Appl. No.:
11/591253
Inventors:
Stanley D'Andrea - Wallingford CT, US
Zhizhen Barbara Zheng - Cheshire CT, US
Jeffrey Allen Campbell - Glen Gardner NJ, US
Fiona McPhee - Wallingford CT, US
Andrew Charles Good - Wallingford CT, US
Paul Michael Scola - Glastonbury CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/00
US Classification:
514 9
Abstract:
Macrocyclic peptides are disclosed having the general formula:.

Combinations Of Hepatitis C Virus Inhibitors

View page
US Patent:
8415374, Apr 9, 2013
Filed:
Oct 7, 2010
Appl. No.:
12/899840
Inventors:
Julie A. Lemm - Durham CT, US
Stacey A. Voss - Wallingford CT, US
Min Gao - Madison CT, US
Susan E. Chaniewski - South Glastonbury CT, US
Amy K. Sheaffer - Meriden CT, US
Fiona McPhee - Wallingford CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/47
A61K 31/445
US Classification:
514312, 514313, 514314, 514315
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.

Substituted Cycloalkyl P1' Hepatitis C Virus Inhibitors

View page
US Patent:
20040077551, Apr 22, 2004
Filed:
May 20, 2003
Appl. No.:
10/441428
Inventors:
Jeffrey Campbell - Cheshire CT, US
Stanley D'Andrea - Meriden CT, US
Andrew Good - Wallingford CT, US
Jianqing Li - Guilford CT, US
Fiona Mcphee - Wallingford CT, US
Amy Ripka - Cambridge MA, US
Paul Scola - Glastonbury CT, US
Yong Tu - Cheshire CT, US
International Classification:
A61K038/05
C07K005/06
C 07D 4 3/02
US Classification:
514/018000, 530/331000, 546/153000
Abstract:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Combinations Of Hepatitis C Virus Inhibitors

View page
US Patent:
20120196794, Aug 2, 2012
Filed:
Aug 1, 2011
Appl. No.:
13/195317
Inventors:
Min Gao - Madison CT, US
David F. Gardiner - Wayne PA, US
Julie A. Lemm - Durham CT, US
Fiona McPhee - Wallingford CT, US
Stacey A. Voss - Wallingford CT, US
International Classification:
A61K 38/06
A61P 31/14
US Classification:
514 43
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating hepatitis C using such combinations.

Combinations Of Hepatitis C Virus Inhibitors

View page
US Patent:
20130259832, Oct 3, 2013
Filed:
Mar 11, 2013
Appl. No.:
13/792898
Inventors:
Stacey A. Voss - Wallingford CT, US
Min Gao - Madison CT, US
Susan E. Chaniewski - South Glastonbury CT, US
Amy K. Sheaffer - Meriden CT, US
Fiona McPhee - Wallingford CT, US
International Classification:
A61K 38/06
A61K 45/06
A61K 31/4178
US Classification:
424 857, 514 219, 424 854, 514 43
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.

Combinations Of Hepatitis C Virus Inhibitors

View page
US Patent:
20150335655, Nov 26, 2015
Filed:
Jul 31, 2015
Appl. No.:
14/814891
Inventors:
- Princeton NJ, US
David F. Gardiner - Wayne PA, US
Julie A. Lemm - Durham CT, US
Fiona McPhee - Wallingford CT, US
Stacey A. Voss - Wallingford CT, US
International Classification:
A61K 31/55
A61K 31/4725
A61K 31/4178
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating hepatitis C using such combinations.
Control profile
Fiona Mcphee from Watertown, MA, age ~60 Get Report